Neurocrine Biosciences
NBIX
#1655
Rank
ยฃ9.84 B
Marketcap
ยฃ98.09
Share price
1.23%
Change (1 day)
4.13%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Revenue for Neurocrine Biosciences (NBIX)

Revenue in 2024: ยฃ1.87 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current revenue (TTM ) is ยฃ1.98 Billion. In 2024 the company made a revenue of ยฃ1.87 Billion an increase over the revenue in the year 2023 that were of ยฃ1.48 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Neurocrine Biosciences from 1996 to 2024

Annual revenue

Year Revenue Change
2024ยฃ1.87 B26.71%
2023ยฃ1.48 B20.37%
2022ยฃ1.23 B46.54%
2021ยฃ0.83 B9.44%
2020ยฃ0.76 B27.69%
2019ยฃ0.60 B69.05%
2018ยฃ0.35 B197.26%
2017ยฃ0.11 B883.75%
2016ยฃ12.15 M-8.87%
2015ยฃ13.34 M
2014N/A-100%
2013ยฃ1.76 M-94.62%
2012ยฃ32.87 M-33.99%
2011ยฃ49.8 M129.5%
2010ยฃ21.7 M1089.22%
2009ยฃ1.82 M-32.72%
2008ยฃ2.71 M340.2%
2007ยฃ0.61 M-96.92%
2006ยฃ20.03 M-72.12%
2005ยฃ71.84 M61.93%
2004ยฃ44.36 M-42.94%
2003ยฃ77.74 M590.84%
2002ยฃ11.25 M-60.43%
2001ยฃ28.44 M191.02%
2000ยฃ9.77 M-6.05%
1999ยฃ10.4 M8.12%
1998ยฃ9.62 M-39.44%
1997ยฃ15.88 M41.7%
1996ยฃ11.21 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
ยฃ46.56 B 2,240.40%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ44.23 B 2,123.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ44.06 B 2,114.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
ยฃ0.52 B-73.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
ยฃ0.05 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
ยฃ0.61 B-69.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
ยฃ6.56 M-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
ยฃ1.74 B-12.41%๐Ÿ‡ฌ๐Ÿ‡ง UK